Logo image of REX

REX AMERICAN RESOURCES CORP (REX) Stock Fundamental Analysis

USA - NYSE:REX - US7616241052 - Common Stock

30.59 USD
+0.02 (+0.07%)
Last: 10/10/2025, 5:05:00 PM
30.59 USD
0 (0%)
After Hours: 10/10/2025, 5:05:00 PM
Fundamental Rating

6

Overall REX gets a fundamental rating of 6 out of 10. We evaluated REX against 211 industry peers in the Oil, Gas & Consumable Fuels industry. While REX has a great health rating, its profitability is only average at the moment. REX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year REX was profitable.
In the past year REX had a positive cash flow from operations.
Each year in the past 5 years REX has been profitable.
Each year in the past 5 years REX had a positive operating cash flow.
REX Yearly Net Income VS EBIT VS OCF VS FCFREX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

The Return On Assets of REX (7.33%) is better than 75.83% of its industry peers.
Looking at the Return On Equity, with a value of 9.42%, REX is in line with its industry, outperforming 59.72% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 6.87%, REX is in the better half of the industry, outperforming 62.09% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for REX is significantly below the industry average of 21.57%.
The 3 year average ROIC (6.75%) for REX is below the current ROIC(6.87%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.33%
ROE 9.42%
ROIC 6.87%
ROA(3y)7.34%
ROA(5y)6.43%
ROE(3y)9.47%
ROE(5y)8.27%
ROIC(3y)6.75%
ROIC(5y)6.3%
REX Yearly ROA, ROE, ROICREX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

REX has a Profit Margin (7.91%) which is in line with its industry peers.
In the last couple of years the Profit Margin of REX has grown nicely.
The Operating Margin of REX (9.10%) is worse than 63.03% of its industry peers.
REX's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 13.22%, REX is doing worse than 68.72% of the companies in the same industry.
In the last couple of years the Gross Margin of REX has grown nicely.
Industry RankSector Rank
OM 9.1%
PM (TTM) 7.91%
GM 13.22%
OM growth 3Y3.74%
OM growth 5Y115.56%
PM growth 3Y10.21%
PM growth 5Y38.58%
GM growth 3Y4.03%
GM growth 5Y23.89%
REX Yearly Profit, Operating, Gross MarginsREX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), REX is destroying value.
Compared to 1 year ago, REX has less shares outstanding
The number of shares outstanding for REX has been reduced compared to 5 years ago.
There is no outstanding debt for REX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
REX Yearly Shares OutstandingREX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
REX Yearly Total Debt VS Total AssetsREX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

REX has an Altman-Z score of 7.28. This indicates that REX is financially healthy and has little risk of bankruptcy at the moment.
REX's Altman-Z score of 7.28 is amongst the best of the industry. REX outperforms 91.47% of its industry peers.
REX has a debt to FCF ratio of 0.29. This is a very positive value and a sign of high solvency as it would only need 0.29 years to pay back of all of its debts.
The Debt to FCF ratio of REX (0.29) is better than 92.42% of its industry peers.
REX has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
REX's Debt to Equity ratio of 0.01 is amongst the best of the industry. REX outperforms 83.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.29
Altman-Z 7.28
ROIC/WACC0.78
WACC8.78%
REX Yearly LT Debt VS Equity VS FCFREX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M 500M

2.3 Liquidity

REX has a Current Ratio of 10.53. This indicates that REX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 10.53, REX belongs to the top of the industry, outperforming 95.73% of the companies in the same industry.
REX has a Quick Ratio of 9.68. This indicates that REX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 9.68, REX belongs to the best of the industry, outperforming 95.26% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 10.53
Quick Ratio 9.68
REX Yearly Current Assets VS Current LiabilitesREX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

4

3. Growth

3.1 Past

REX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.19%.
REX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 51.01% yearly.
REX shows a decrease in Revenue. In the last year, the revenue decreased by -9.48%.
REX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.99% yearly.
EPS 1Y (TTM)-5.19%
EPS 3Y4.1%
EPS 5Y51.01%
EPS Q2Q%-38.46%
Revenue 1Y (TTM)-9.48%
Revenue growth 3Y-6.05%
Revenue growth 5Y8.99%
Sales Q2Q%7.03%

3.2 Future

REX is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.03% yearly.
The Revenue is expected to grow by 10.00% on average over the next years. This is quite good.
EPS Next Y-52.42%
EPS Next 2Y-4.03%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.32%
Revenue Next 2Y10%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
REX Yearly Revenue VS EstimatesREX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
REX Yearly EPS VS EstimatesREX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

REX is valuated reasonably with a Price/Earnings ratio of 9.30.
Based on the Price/Earnings ratio, REX is valued a bit cheaper than 79.62% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.70. REX is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 10.10 indicates a reasonable valuation of REX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of REX indicates a somewhat cheap valuation: REX is cheaper than 71.09% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.15. REX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.3
Fwd PE 10.1
REX Price Earnings VS Forward Price EarningsREX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

REX's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of REX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 89.74
EV/EBITDA 8.34
REX Per share dataREX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The decent profitability rating of REX may justify a higher PE ratio.
REX's earnings are expected to decrease with -4.03% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.18
EPS Next 2Y-4.03%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

REX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

REX AMERICAN RESOURCES CORP

NYSE:REX (10/10/2025, 5:05:00 PM)

After market: 30.59 0 (0%)

30.59

+0.02 (+0.07%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-25 2025-08-25/bmo
Earnings (Next)12-01 2025-12-01/bmo
Inst Owners85.18%
Inst Owner Change0%
Ins Owners14.29%
Ins Owner Change3.49%
Market Cap1.01B
Analysts80
Price TargetN/A
Short Float %N/A
Short Ratio2.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.75%
Min Revenue beat(2)-4.71%
Max Revenue beat(2)-2.79%
Revenue beat(4)2
Avg Revenue beat(4)1.28%
Min Revenue beat(4)-4.71%
Max Revenue beat(4)9.23%
Revenue beat(8)3
Avg Revenue beat(8)0.51%
Revenue beat(12)6
Avg Revenue beat(12)1.89%
Revenue beat(16)9
Avg Revenue beat(16)2.48%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 9.3
Fwd PE 10.1
P/S 1.56
P/FCF 89.74
P/OCF 14.19
P/B 1.85
P/tB 1.85
EV/EBITDA 8.34
EPS(TTM)3.29
EY10.76%
EPS(NY)3.03
Fwd EY9.91%
FCF(TTM)0.34
FCFY1.11%
OCF(TTM)2.16
OCFY7.05%
SpS19.66
BVpS16.51
TBVpS16.51
PEG (NY)N/A
PEG (5Y)0.18
Profitability
Industry RankSector Rank
ROA 7.33%
ROE 9.42%
ROCE 8.92%
ROIC 6.87%
ROICexc 12.91%
ROICexgc 12.91%
OM 9.1%
PM (TTM) 7.91%
GM 13.22%
FCFM 1.73%
ROA(3y)7.34%
ROA(5y)6.43%
ROE(3y)9.47%
ROE(5y)8.27%
ROIC(3y)6.75%
ROIC(5y)6.3%
ROICexc(3y)16.25%
ROICexc(5y)14.31%
ROICexgc(3y)16.25%
ROICexgc(5y)14.31%
ROCE(3y)8.77%
ROCE(5y)8.17%
ROICexcg growth 3Y-10.04%
ROICexcg growth 5Y127.29%
ROICexc growth 3Y-10.04%
ROICexc growth 5Y127.29%
OM growth 3Y3.74%
OM growth 5Y115.56%
PM growth 3Y10.21%
PM growth 5Y38.58%
GM growth 3Y4.03%
GM growth 5Y23.89%
F-Score4
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.29
Debt/EBITDA 0.04
Cap/Depr 356.45%
Cap/Sales 9.23%
Interest Coverage 250
Cash Conversion 93.79%
Profit Quality 21.93%
Current Ratio 10.53
Quick Ratio 9.68
Altman-Z 7.28
F-Score4
WACC8.78%
ROIC/WACC0.78
Cap/Depr(3y)192.86%
Cap/Depr(5y)131.33%
Cap/Sales(3y)5.81%
Cap/Sales(5y)4.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.19%
EPS 3Y4.1%
EPS 5Y51.01%
EPS Q2Q%-38.46%
EPS Next Y-52.42%
EPS Next 2Y-4.03%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.48%
Revenue growth 3Y-6.05%
Revenue growth 5Y8.99%
Sales Q2Q%7.03%
Revenue Next Year3.32%
Revenue Next 2Y10%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-22.53%
EBIT growth 3Y-2.54%
EBIT growth 5Y134.95%
EBIT Next Year3.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-73.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.77%
OCF growth 3Y-11.21%
OCF growth 5Y44.19%